Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
BLU-451 for Lung Cancer
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is testing a new cancer drug to see if it is safe and effective. The drug will be given to patients once or twice a day for 21 days.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.